Israel Chemicals Ltd.:企業の戦略・SWOT・財務情報

◆英語タイトル:Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6019
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Israel Chemicals Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Israel Chemicals Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Israel Chemicals Ltd. (ICL or ‘the company’) is a manufacturer and marketer of fertilizers, performance products and industrial products. The company’s product portfolio comprises bromine, potash, phosphoric acid, phosphate, specialty fertilizers and flame retardants. It also produces and markets bromine and phosphorus compounds for the automotive, construction, electronics, and oil and gas industries. ICL extracts raw materials and utilize processing and product formulation technologies to add value to customers in three end-markets: agriculture, food and engineered materials. The company operates in Germany, the US, Israel, Brazil, France, Spain, China, the UK, Argentina, Austria, Australia and Mexico. ICL is headquartered in Tel-Aviv, Israel.

Scope

- Detailed information on Israel Chemicals Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Israel Chemicals Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Israel Chemicals Ltd. including a breakdown and examination of key business segments
- Intelligence on Israel Chemicals Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Israel Chemicals Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Israel Chemicals Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Israel Chemicals Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Israel Chemicals Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Israel Chemicals Ltd.: Company Overview 9
Israel Chemicals Ltd.: Overview and Key Facts 9
Israel Chemicals Ltd.: Overview 9
Israel Chemicals Ltd.: Key Facts 9
Israel Chemicals Ltd.: Key Employees 11
Israel Chemicals Ltd.: Key Employee Biographies 13
Israel Chemicals Ltd.: Major Products and Services 18
Israel Chemicals Ltd.: Company History 19
Israel Chemicals Ltd.: Management Statement 24
Israel Chemicals Ltd.: Locations and Subsidiaries 27
Israel Chemicals Ltd.: Key Competitors 28
Israel Chemicals Ltd.: Company Analysis 29
Israel Chemicals Ltd.: Business Description 29
Israel Chemicals Ltd.: SWOT Analysis 31
Israel Chemicals Ltd.: SWOT Overview 31
Israel Chemicals Ltd.: Strengths 31
Israel Chemicals Ltd.: Weaknesses 32
Israel Chemicals Ltd.: Opportunities 33
Israel Chemicals Ltd.: Threats 33
Israel Chemicals Ltd.: Corporate Financial Deals Activity 35
Israel Chemicals Ltd.: Financial Deals Overview 35
Israel Chemicals Ltd.: Targets and Partners 37
Israel Chemicals Ltd.: Top Deals 2014 – 2018YTD* 38
Israel Chemicals Ltd.: Advisors 39
Israel Chemicals Ltd.: Top Legal Advisors 39
Israel Chemicals Ltd.: Top Financial Advisors 39
Israel Chemicals Ltd.: Mergers and Acquisitions 40
Israel Chemicals Ltd.: Corporate Venturing 41
Israel Chemicals Ltd.: Capital Raising 42
Israel Chemicals Ltd.: Partnership 43
Israel Chemicals Ltd.: Divestments 44
Israel Chemicals Ltd.: Recent Developments 45
Israel Chemicals Ltd.: News and Events Summary 45
Israel Chemicals Ltd.: Contracts 48
Israel Chemicals Ltd.: Corporate Governance 50
Israel Chemicals Ltd.: Financial Deals 50
Israel Chemicals Ltd.: Financial Performance 51
Israel Chemicals Ltd.: Regulatory and Legal Events 51
Israel Chemicals Ltd.: Strategy and Operations 51
Appendix 53
Contact Us 53
Methodology 53
About MarketLine 54

List of Tables
Table 1: Israel Chemicals Ltd.: Key Facts
Table 2: Israel Chemicals Ltd.: Key Employees
Table 3: Israel Chemicals Ltd.: Company History
Table 4: Israel Chemicals Ltd.: Locations and Subsidiaries
Table 5: Israel Chemicals Ltd.: Key Competitors
Table 6: Israel Chemicals Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Israel Chemicals Ltd.: M&A Activity by Geography (TTM*)
Table 8: Israel Chemicals Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Israel Chemicals Ltd.: M&A Average Deal Size - Value (US$m)
Table 10: Israel Chemicals Ltd.: Targets and Partners
Table 11: Israel Chemicals Ltd.: Top Deals 2014 - 2018YTD*
Table 12: Israel Chemicals Ltd.: Legal Advisor Ranking by Value (US$m)
Table 13: Israel Chemicals Ltd.: Financial Advisor Ranking by Value (US$m)
Table 14: Israel Chemicals Ltd.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 15: Israel Chemicals Ltd.: M&A Activity by Geography (2014 - YTD*2018)
Table 16: Israel Chemicals Ltd.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 17: Israel Chemicals Ltd.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 18: Israel Chemicals Ltd.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 19: Israel Chemicals Ltd.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 20: Israel Chemicals Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 21: Israel Chemicals Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 22: Israel Chemicals Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 23: Israel Chemicals Ltd.: Divestments by Geography (2014 - YTD*2018)
Table 24: Israel Chemicals Ltd.: News and Events Summary
Table 25: Israel Chemicals Ltd.: Contracts
Table 26: Israel Chemicals Ltd.: Corporate Governance
Table 27: Israel Chemicals Ltd.: Financial Deals
Table 28: Israel Chemicals Ltd.: Financial Performance
Table 29: Israel Chemicals Ltd.: Regulatory and Legal Events
Table 30: Israel Chemicals Ltd.: Strategy and Operations

List of Figures
Figure 1: Israel Chemicals Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Israel Chemicals Ltd.: M&A Activity by Geography (TTM*)
Figure 3: Israel Chemicals Ltd.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Israel Chemicals Ltd.: M&A Average Deal Size - Value (US$m)
Figure 5: Israel Chemicals Ltd.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Israel Chemicals Ltd.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Israel Chemicals Ltd.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Israel Chemicals Ltd.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Israel Chemicals Ltd.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Israel Chemicals Ltd.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Israel Chemicals Ltd.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Israel Chemicals Ltd.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Israel Chemicals Ltd.: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: Israel Chemicals Ltd.: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Israel Chemicals Ltd.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CALBEE, Inc. (2229):企業の財務・戦略的SWOT分析
    CALBEE, Inc. (2229) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Alkane Energy Plc:電力:M&Aディール及び事業提携情報
    Summary Alkane Energy Plc (Alkane Energy), a subsidiary of Basalt Infrastructure Partners LLP, is a diversified company. The company power from coal mine methane and natural gas facilities. It has natural gas, coal bed methane, coal mine methane and shale gas. Alkane Energy design, builds and operat …
  • PureCircle Ltd:企業の戦略・SWOT・財務情報
    PureCircle Ltd - Strategy, SWOT and Corporate Finance Report Summary PureCircle Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Leukocare AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Leukocare AG (Leukocare) is a clinical-stage biotechnology company that offers technologies for stabilizing proteins to increase shelf-life and to facilitate terminal sterilization by irradiation or gas. The company’s services include development of spray drying and spray freeze-drying proce …
  • Mohawk Industries, Inc.:企業の戦略・SWOT・財務情報
    Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mohawk Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Arab African International Bank:企業の戦略・SWOT・財務情報
    Arab African International Bank - Strategy, SWOT and Corporate Finance Report Summary Arab African International Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Unichem Laboratories Ltd (UNICHEMLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API's). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, …
  • Split Rock Partners, LLC:企業の戦略・SWOT・財務情報
    Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report Summary Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fujirebio Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent con …
  • Alteogen Inc (196170):製薬・医療:M&Aディール及び事業提携情報
    Summary Alteogen Inc (Alteogen) is a biotech company that develops proprietary antibody-drug conjugate and antibody biosimilars. The company’s pipeline products include ALT-P1, ALT-Q2, ALT-P7, ALT-Q5, ALT-L9 and ALT-L2. Its products are used for long-acting human growth hormone, long-acting factor V …
  • Xantrex LLC:企業の戦略的SWOT分析
    Xantrex LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CEL-SCI Corp (CVM):製薬・医療:M&Aディール及び事業提携情報
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Guyana Goldfields Inc:企業の戦略・SWOT・財務情報
    Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report Summary Guyana Goldfields Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Bureau Veritas SA:企業の戦略・SWOT・財務情報
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • RPM International Inc:企業の戦略・SWOT・財務情報
    RPM International Inc - Strategy, SWOT and Corporate Finance Report Summary RPM International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CRH Medical Corp (CRH):医療機器:M&Aディール及び事業提携情報
    Summary CRH Medical Corp (CRH Medical), formerly Medsurge Medical Products Corp, is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H …
  • Zanders GmbH:企業の戦略的SWOT分析
    Zanders GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kiromic Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kiromic Inc (Kiromic) is a biotechnology company focused on developing immuno-oncology therapies. Its pipeline products include BSK01, an injectable drug that harness dendritic cells for the treatment of solid and hematological malignancies; BSK02, a synthetic oral cancer immunotherapy compo …
  • Ameresco Inc (AMRC)-エネルギー分野:企業M&A・提携分析
    Summary Ameresco, Inc. (Ameresco) provides comprehensive energy services, including energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions. It also offers energy infrastructure facility upgrade; and development, construction and operation of renewable energy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆